Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer

NCT04406831 is registered in ClinicalTrials.gov with Nuvance Health as lead sponsor.

NCT NCT04406831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04406831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
Lead sponsor
Nuvance Health
Phase
Observational
Overall status
Recruiting
Start date
April 30, 2015
Completion date
April 30, 2030
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer stage iii, pancreatic cancer stage iv, pancreatic ductal adenocarcinoma, pancreatic neoplasms